Peri-implantitis and Osteonecrosis of the Jaws
Mar 01, 2014
from 09:00 AM to 05:00 PM
|Where||UCLA School of Dentistry|
|Add event to calendar||
Time: 9:00 am - 5:00 pm
or E-mail our Registrar
Current guidelines for prevention and treatment
Since implant survival and success are greater than 95% in most short-term studies, long-term maintenance has come to the forefront of implant therapy. Although most implant surgeons and restorative dentists know that maintenance is required after implant therapy, there are no universally accepted schedules, techniques, or guidelines recommended. In the past few years, several consensus conferences have been held and systematic reviews have been written to determine accurate diagnosis, prevalence, prevention, and treatment for peri-implantitis. This course will address current concepts in implant maintenance, peri-implantitis, and present some novel concepts for treatment.
Osteonecrosis of the jaws (ONJ) is a devastating complication of potent antiresorptive medications utilized for benign and malignant disorders of bone metabolism. Bisphosphonate related ONJ (BRONJ) was first identified in 2003 and 2004, and its prevalence is reported as high as 12%. Difficulties with diagnosis, prevention and treatment exist, often making dentists uncomfortable recognizing and treating patients on these medications. This course will discuss ONJ risk, diagnosis, prevention, and management. Specific case discussions will also be included.
- Review peri-implantitis and goals for prevention, maintenance, and treatment.
- Case discussions for diagnose and manage of peri-implantitis
- Understand peri-implant mucositis and peri-implantitis etiology and diagnosis
- Understand prevention and treatment of peri-implant disease
- Identify risk factors for development of peri-implant disease
- Bisphosphonates and other medications associated with ONJ
- Current guidelines for prevention and management of ONJ
- Understand the disease process of antiresorptive related osteonecrosis of the jaws (ONJ)
- Increase comfort level in treating patients with or at risk for ONJ
- Management of ONJ and when patients need aggressive surgical therapy
Tara Aghaloo, DDS, MD, Associate Professor, Oral & Maxillofacial Surgery, Diagnositc & Surgical Sciences, Assistant Dean, Clinical Research, UCLA School of Dentistry